Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05753930
What this trial is testing

Imlifidase Prior to Kidney Transplant in Highly Sensitised Children

Who this might be right for
Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB 10
Early research (Phase 1)Study completedNCT02210663
What this trial is testing

Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 16
Testing effectiveness (Phase 2)Ended earlyNCT01806064
What this trial is testing

Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Tracon Pharmaceuticals Inc. 173
Large-scale testing (Phase 3)Ended earlyNCT00352079
What this trial is testing

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Who this might be right for
Bladder Cancer
NCIC Clinical Trials Group 41
Post-approval studies (Phase 4)Looking for participantsNCT07259512
What this trial is testing

Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure

Who this might be right for
Chronic Kidney DiseaseHeart Failure With Reduced Ejection Fraction (HFrEF)
Evi Liliek Wulandari 80
Early research (Phase 1)UnknownNCT04460456
What this trial is testing

SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors

Who this might be right for
HER2 Positive Solid Tumors
Silverback Therapeutics 58
Early research (Phase 1)Study completedNCT03660241
What this trial is testing

A Renal Impairment Study for PF-04965842

Who this might be right for
Renal Impairment
Pfizer 23
Large-scale testing (Phase 3)Looking for participantsNCT06960577
What this trial is testing

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Who this might be right for
Urinary Bladder NeoplasmsImmune Checkpoint InhibitorsMethotrexate+4 more
AstraZeneca 150
Post-approval studies (Phase 4)Study completedNCT01505439
What this trial is testing

Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence

Who this might be right for
Stress Urinary IncontinenceUrgency Urinary Incontinence
Jeong Gu Lee 311
Testing effectiveness (Phase 2)UnknownNCT05211557
What this trial is testing

Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer

Who this might be right for
Ovarian Cancer
The Affiliated Hospital of Xuzhou Medical University 15
Large-scale testing (Phase 3)Study completedNCT01895205
What this trial is testing

Treatment of Women After Severe Postpartum Haemorrhage

Who this might be right for
Severe Postpartum Haemorrhage
Pharmacosmos A/S 13
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Early research (Phase 1)WithdrawnNCT05406219
What this trial is testing

Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function

Who this might be right for
Diabetic Neuropathic PainRenal ImpairmentHealthy Volunteers
Bayer
Testing effectiveness (Phase 2)Study completedNCT01147666
What this trial is testing

Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis

Who this might be right for
End Stage Renal DiseaseAnemia
Kyntra Bio 161
Early research (Phase 1)Study completedNCT03071757
What this trial is testing

The Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 139
Testing effectiveness (Phase 2)UnknownNCT04590625
What this trial is testing

Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zhongshan Hospital Xiamen University 58
Not applicableLooking for participantsNCT05326399
What this trial is testing

Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment

Who this might be right for
Liver TransplantationRenal Insufficiency, Chronic
RenJi Hospital 369
Testing effectiveness (Phase 2)Study completedNCT02015104
What this trial is testing

Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG

Who this might be right for
Bladder Cancer
National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Looking for participantsNCT03949855
What this trial is testing

Belimumab With Rituximab for Primary Membranous Nephropathy

Who this might be right for
Membranous NephropathyNephrotic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 58
Testing effectiveness (Phase 2)Study completedNCT00444314
What this trial is testing

Phase 2 Study of Panzem® NCD Alone and Combined With Sunitinib Malate in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
CASI pharmaceuticals, Inc. 82
Next Page